We are live on ! Find out more
DGX icon

Quest Diagnostics
DGX

558 hedge funds and large institutions have $11.2B invested in Quest Diagnostics in 2016 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 205 increasing their positions, 197 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $37.9M | Put options by funds: $23.6M

27% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 41

22% more funds holding in top 10

Funds holding in top 10: 9 → 11 (+2)

21% more capital invested

Capital invested by funds: $9.29B → $11.2B (+$1.95B)

3.82% more ownership

Funds ownership: 93.85% → 97.66% (+3.8%)

4% more repeat investments, than reductions

Existing positions increased: 205 | Existing positions reduced: 197

0% more funds holding

Funds holding: 557 → 558 (+1)

Holders
558
Holders Change
+1
Holders Change %
+0.18%
% of All Funds
14.89%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.29%
New
52
Increased
205
Reduced
197
Closed
41
Calls
$37.9M
Puts
$23.6M
Net Calls
+$14.3M
Net Calls Change
+$1.29M

Top Buyers

1
Macquarie Group
Macquarie Group
Australia
+$685M
2
Victory Capital Management
Victory Capital Management
Texas
+$95.2M
3
American Century Companies
American Century Companies
Missouri
+$77.8M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$74.6M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$54.9M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$229M
2
Royal London Asset Management
Royal London Asset Management
United Kingdom
-$188M
3
Allianz Asset Management
Allianz Asset Management
Germany
-$70.2M
4
HM
HealthCor Management
New York
-$53.3M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$52.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
AT
226
Argent Trust
Texas
$2.14M – – –
URS
227
Utah Retirement Systems
Utah
$2.11M +$15.2K +200 +0.8%
AIP
228
Ameritas Investment Partners
Nebraska
$2.1M -$1.2M -15,735 -38%
OA
229
Oak Associates
Ohio
$2.07M +$312K +4,100 +19%
CBOA
230
Commonwealth Bank of Australia
Australia
$2.05M -$62K -814 -3%
CIBC World Market
231
CIBC World Market
Ontario, Canada
$2M -$30.5K -401 -2%
FP
232
FDO Partners
Massachusetts
$1.98M +$392K +5,148 +27%
CCM
233
Coldstream Capital Management
Washington
$1.96M +$12.3K +162 +0.7%
SOADOR
234
State of Alaska Department of Revenue
Alaska
$1.94M +$3.27K +43 +0.2%
LOAMS
235
Lombard Odier Asset Management (Switzerland)
Switzerland
$1.93M -$404K -5,307 -18%
PP
236
Paloma Partners
Connecticut
$1.9M +$1.77M +23,298 New
AC
237
Amici Capital
New York
$1.78M – – –
JCM
238
Jag Capital Management
Missouri
$1.76M -$2.21K -29 -0.1%
Mitsubishi UFJ Asset Management
239
Mitsubishi UFJ Asset Management
Japan
$1.74M +$31.3K +411 +2%
CIM
240
CenturyLink Investment Management
Colorado
$1.7M -$8.15K -107 -0.5%
CIBC Asset Management
241
CIBC Asset Management
Ontario, Canada
$1.69M +$29.2K +384 +2%
SLAM
242
Swiss Life Asset Management
$1.68M +$996K +13,078 +173%
ProShare Advisors
243
ProShare Advisors
Maryland
$1.66M +$1.9K +25 +0.1%
KFA
244
Kays Financial Advisory
Georgia
$1.63M +$239K +3,133 +19%
KCPG
245
Kavar Capital Partners Group
Kansas
$1.63M -$15.2K -200 -1%
Cambridge Investment Research Advisors
246
Cambridge Investment Research Advisors
Iowa
$1.6M +$746K +9,800 +99%
William Blair & Company
247
William Blair & Company
Illinois
$1.59M +$27.6K +362 +2%
RJFSA
248
Raymond James Financial Services Advisors
Florida
$1.56M -$86.2K -1,132 -6%
TAF
249
Tredje AP-fonden
Sweden
$1.56M +$678K +8,906 +87%
MSA
250
Mason Street Advisors
Wisconsin
$1.55M +$2.89K +38 +0.2%
8 9
10
11 12

DGX Hedge Fund Activity: Q2 2016 in Review

558 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q2 2016, worth a combined $11.2B — up 21% from $9.29B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new DGX positions and 41 closed out — a net gain of 11 holders — while 205 added to existing stakes and 197 trimmed.

The largest buyer was Macquarie Group, adding an estimated $685M. The largest seller was T. Rowe Price Associates, cutting an estimated $229M.

  • 558 institutional investors held Quest Diagnostics (DGX) as of Q2 2016, up from 557 in Q1 2016.
  • Funds reported $11.2B of Quest Diagnostics stock for Q2 2016, up 21% quarter-over-quarter.
  • 52 funds opened new Quest Diagnostics positions in Q2 2016 and 41 closed out, a net change of +11 holders.
  • The largest Quest Diagnostics buyer in Q2 2016 was Macquarie Group, an estimated $685M added.
  • The largest Quest Diagnostics seller in Q2 2016 was T. Rowe Price Associates, an estimated $229M sold.

Based on aggregated 13F filings for Q2 2016.